2022
DOI: 10.1177/10781552211070933
|View full text |Cite
|
Sign up to set email alerts
|

ISOPP Standards for the Safe Handling of Cytotoxics

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
10
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 23 publications
(11 citation statements)
references
References 155 publications
(198 reference statements)
1
10
0
Order By: Relevance
“…The International Society of Pharmacy Practitioners (ISOPP) released the Standards for the Safe Handling of Cytotoxic Drugs in 2022. 32 Guidance is provided for specific categories of SACT such as monoclonal antibodies. It does not provide audit recommendations but provides an audit toolkit.…”
Section: Resultsmentioning
confidence: 99%
“…The International Society of Pharmacy Practitioners (ISOPP) released the Standards for the Safe Handling of Cytotoxic Drugs in 2022. 32 Guidance is provided for specific categories of SACT such as monoclonal antibodies. It does not provide audit recommendations but provides an audit toolkit.…”
Section: Resultsmentioning
confidence: 99%
“…Otherwise, it is well known that headache is a less common side effect of cyclophosphamide treatment, which may be due to the elevation of blood pressure which could happen during the infusion of cyclophosphamide. No data were found about the prevalence of headaches during cyclophosphamide infusion 26 , 27 . The rate of using the treatment for headaches in our study was higher in both groups compared to the previous studies 25 , 26 , 28 .…”
Section: Discussionmentioning
confidence: 99%
“…No data were found about the prevalence of headaches during cyclophosphamide infusion 26 , 27 . The rate of using the treatment for headaches in our study was higher in both groups compared to the previous studies 25 , 26 , 28 . The facility of buying analgesics in Syria may explain these differences.…”
Section: Discussionmentioning
confidence: 99%
“…The therapeutic benefits of ADs with carcinogenic, mutagenic, and teratogenic properties outweigh the risks for patients but they represent a risk for health care workers. The long-term occupational exposures have been associated with adverse health outcomes including reproduction toxicity or cancer ( 3 , 4 ). Acute adverse health effects in such as skin rashes and hair loss have been also reported ( 5 , 6 ).…”
Section: Introductionmentioning
confidence: 99%
“…Occupational exposures of health care staff to ADs may occur in pharmacies and hospitals through direct dermal contact, inhalation, accidental ingestion, or indirectly via surfaces contaminated by ADs during their preparation, handling or administration to patients ( 3 , 7 ). To minimize the occupational exposure and achieve maximum product safety, the preparation of ADs is regulated.…”
Section: Introductionmentioning
confidence: 99%